| PERIOD ENDING | 2-Aug-09 | 3-May-09 | 1-Feb-09 | 2-Nov-08 | | Total Revenue | 28,841 | 34,070 | 30,687 | 36,458 | | Cost of Revenue | 4,837 | 11,774 | 11,873 | 12,352 | | | Gross Profit | 24,004 | 22,296 | 18,814 | 24,106 | | | Operating Expenses | | Research Development | 11,197 | 14,275 | 15,296 | 19,047 | | Selling General and Administrative | 14,153 | 16,231 | 18,128 | 22,217 | | Non Recurring | 703 | 2,049 | 63,374 | 3,307 | | Others | 305 | 334 | 378 | 838 | | | | Total Operating Expenses | 26,358 | 32,889 | 97,176 | 45,409 | | | | Operating Income or Loss | (2,354) | (10,593) | (78,362) | (21,303) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (405) | (235) | 1,003 | (781) | | Earnings Before Interest And Taxes | (2,759) | (10,828) | (77,359) | (22,084) | | Interest Expense | 1,157 | 860 | 692 | 692 | | Income Before Tax | (3,916) | (11,688) | (78,051) | (22,776) | | Income Tax Expense | 396 | (2,177) | (628) | 3,130 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,312) | (9,511) | (77,423) | (25,906) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,312) | (9,511) | (77,423) | (25,906) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,312) | ($9,511) | ($77,423) | ($25,906) |
|
0.29% Nasdaq 
0.01 (0.41%) 
Income Statement
